0

Back to The Evolving Paradigm of Cervical Cancer Prevention
The Evolving Paradigm of Cervical Cancer Prevention

The Evolving Paradigm of Cervical Cancer Prevention

 

 

 

Release Date: Oct 2019

 

CC: PC, MK, PBL, ICS, SBP

 

Ritu Nayar, MD, FASCP

Medical Director of Cytopathology, Northwestern Memorial Hospital, Chicago, IL; Associate Professor of Cytopathology, Northwestern University, Chicago, IL

 

Learning Objectives:

 

After completing this course, participants will be able to:

 

  • Identify what cervical cancer screening options are recommended at various age groups.
  • Recognize the types of HPV vaccines, vaccination dosing, and uptake available in the United States.
  • Understand the Risk-Based ASCCP Management Guidelines Update that is currently in progress.

Who should attend? Practicing Pathologists, Fellows in Cytopathology, Residents, Cytotechnologists

 

Description:

This presentation will cover updates on cervical cancer screening options in the United States, HPV vaccine delivery, dosing and uptake, and the principles of the ASCCP Risk Based Management Guidelines that are currently in progress. Reference will be made to the justification of retaining co-testing in the United States, laboratory considerations for those offering cervical cytology, and HPV testing for cervical cancer screening. The data reasoning for a risk-based management approach will also be discussed.

  • List Price: $225.00
Item Details:
The Evolving Paradigm of Cervical Cancer Prevention
Back to The Evolving Paradigm of Cervical Cancer Prevention

Bought This Bought That ...